Salud financiera de hoja de balance de CSPC Pharmaceutical Group
Salud financiera controles de criterios 5/6
CSPC Pharmaceutical Group tiene un patrimonio de accionistas total de CN¥35.0B y una deuda total de CN¥450.2M, lo que sitúa su ratio deuda-patrimonio en 1.3%. Sus activos y pasivos totales son CN¥46.3B y CN¥11.3B respectivamente. El BAIT de CSPC Pharmaceutical Group es de CN¥7.0B, por lo que su ratio de cobertura de intereses es de -30. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥13.8B.
Información clave
1.3%
Ratio deuda-patrimonio
CN¥450.22m
Deuda
| Ratio de cobertura de intereses | -30x |
| Efectivo | CN¥13.76b |
| Patrimonio | CN¥35.02b |
| Total pasivo | CN¥11.26b |
| Activos totales | CN¥46.28b |
Actualizaciones recientes sobre salud financiera
Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?
Sep 21
Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?
Jun 20We Think CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt With Ease
Dec 26CSPC Pharmaceutical Group (HKG:1093) Could Easily Take On More Debt
Sep 15Recent updates
CSPC Pharmaceutical Group (HKG:1093) Will Pay A Dividend Of CN¥0.14
Apr 29There's Reason For Concern Over CSPC Pharmaceutical Group Limited's (HKG:1093) Price
Apr 22CSPC Pharmaceutical Group's (HKG:1093) Dividend Will Be CN¥0.14
Apr 01CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 49% Below Their Intrinsic Value Estimate
Jan 22Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E
Jan 04Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?
Oct 22Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?
Sep 21CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price
Jul 09Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?
Jun 20CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 01CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11
Apr 04CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price
Mar 12We Think CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt With Ease
Dec 26CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 98% Above Its Share Price
Oct 18CSPC Pharmaceutical Group (HKG:1093) Could Easily Take On More Debt
Sep 15CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At CN¥0.10
Aug 26CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At HK$0.10
May 27CSPC Pharmaceutical Group (HKG:1093) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Apr 27CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To HK$0.10
Apr 04Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥26.7B) de 1093 superan a sus pasivos a corto plazo (CN¥10.2B).
Pasivo a largo plazo: Los activos a corto plazo de 1093 (CN¥26.7B) superan a sus pasivos a largo plazo (CN¥1.1B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 1093 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 1093 ha crecido de 0.6% a 1.3% en los últimos 5 años.
Cobertura de la deuda: La deuda de 1093 está bien cubierta por el flujo de caja operativo (1041.8%).
Cobertura de intereses: 1093 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.